FDA Issues Five More Warning Letters to Marketers of CBD-Containing Products
It has been a tough week for cannabidiol (CBD) products. In a December 22 post, we discussed the Federal Trade Commission’s first … more
warning letter
With 55% Market Share and the Creation of a New Verb (“JUULing”), JUUL is Now at the Center of a Firestorm (Vaporstorm?) of Attention
On April 24, 2018, FDA announced a number of new actions relating to youth access to and use of JUUL products and … more
Stem Cell Therapy and the Practice of Medicine
Historically, FDA has stated in various contexts that it does not intend to regulate the practice of medicine. Indeed, the Federal Food, … more
When A Device Maker Must Submit a 510(k)
Bloomberg BNA Publications published an article on September 13, 2017, indicating that FDA expects to meet the statutory timeline of November 8 … more